MX2017011363A - Composicion para corregir o prevenir higado graso no alcoholico. - Google Patents

Composicion para corregir o prevenir higado graso no alcoholico.

Info

Publication number
MX2017011363A
MX2017011363A MX2017011363A MX2017011363A MX2017011363A MX 2017011363 A MX2017011363 A MX 2017011363A MX 2017011363 A MX2017011363 A MX 2017011363A MX 2017011363 A MX2017011363 A MX 2017011363A MX 2017011363 A MX2017011363 A MX 2017011363A
Authority
MX
Mexico
Prior art keywords
improving
composition
nonalcoholic fatty
fatty liver
preventing
Prior art date
Application number
MX2017011363A
Other languages
English (en)
Inventor
Kessoku Takaomi
Nakajima Atsushi
Sumida Yoshio
Eguchi Yuichiro
Saito Susumu
Sauchi Yusuke
Original Assignee
Kohjin Life Sciences Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kohjin Life Sciences Co Ltd filed Critical Kohjin Life Sciences Co Ltd
Publication of MX2017011363A publication Critical patent/MX2017011363A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)

Abstract

[Objetivo] Un objetivo de la presente invención es proporcionar una composición para prevenir o corregir la deposición de grasa en el hígado a pesar de la historia de ingesta de alcohol de un nivel que no se causa una enfermedad hepática. [Medios para Solucionar] Los inventores encontraron que el glutatión tiene un efecto de prevenir o corregir la deposición de grasa en el hígado, que no está causada por alcohol, y completaron la presente invención. Entre las enfermedades de grasa no alcohólica, la presente invención es particularmente efectiva en una etapa temprana del tratamiento o en un caso donde el tratamiento para otra enfermedad no se realiza. [Dibujo Seleccionado] Ninguno.
MX2017011363A 2015-03-03 2016-03-02 Composicion para corregir o prevenir higado graso no alcoholico. MX2017011363A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015041317 2015-03-03
PCT/JP2016/056341 WO2016140237A1 (ja) 2015-03-03 2016-03-02 非アルコール性脂肪肝改善又は予防組成物

Publications (1)

Publication Number Publication Date
MX2017011363A true MX2017011363A (es) 2018-03-01

Family

ID=56848248

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017011363A MX2017011363A (es) 2015-03-03 2016-03-02 Composicion para corregir o prevenir higado graso no alcoholico.

Country Status (12)

Country Link
US (4) US20180050078A1 (es)
EP (1) EP3266461A4 (es)
JP (2) JP6890536B2 (es)
CN (1) CN107405376A (es)
AU (1) AU2016226906B2 (es)
BR (1) BR112017018882A2 (es)
CA (1) CA2978251C (es)
MX (1) MX2017011363A (es)
PH (1) PH12017550090A1 (es)
RU (1) RU2746091C2 (es)
TW (1) TWI781906B (es)
WO (1) WO2016140237A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180050078A1 (en) * 2015-03-03 2018-02-22 KOHJIN Life Sciences Co., Ltd. Composition for improving or preventing nonalcoholic fatty liver
JP2019123697A (ja) * 2018-01-18 2019-07-25 京都府公立大学法人 マイオカイン分泌促進剤
RU2706026C1 (ru) * 2018-12-28 2019-11-13 Государственное бюджетное учреждение здравоохранения города Москвы Московский клинический научно-практический центр им. А.С. Логинова Департамента здравоохранения города Москвы Способ лечения неалкогольной жировой болезни печени и сахарного диабета второго типа
CN111602822A (zh) * 2019-02-25 2020-09-01 不二制油集团控股株式会社 用于抑制肝脂肪合成的食品组合物
EP4311540A1 (en) 2022-07-27 2024-01-31 Carepharm S.r.l. Edible herbal composition containing silicon, and procedure for obtaining it

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4559380B2 (ja) 2002-03-01 2010-10-06 日清ファルマ株式会社 肝疾患治療剤
US7078064B2 (en) * 2003-12-03 2006-07-18 George Zabrecky Compositions and methods useful for treating and preventing chronic liver disease, chronic HCV infection and non-alcoholic steatohepatitis
BRPI0602397C1 (pt) * 2006-04-20 2009-11-24 Unicamp composições farmacêuticas para o tratamento das doenças gordurosas do fìgado, obesidade e demais doenças associadas à sìndrome metabólica e métodos de tratamento utilizando-se as referidas composições
MX360827B (es) * 2007-11-30 2018-11-16 Univ California Metodos para tratar la esteatohepatitis no alcoholica (nash) usando productos de cisteamina.
MX2010007426A (es) 2008-01-31 2010-08-18 Astellas Pharma Inc Composiciones farmaceuticas para tratar trastorno del higado graso.
MX360979B (es) * 2011-09-16 2018-11-22 Galectin Therapeutics Inc Composiciones de galacto-ramnogalacturonato para el tratamiento de la esteatohepatitis no alcohólica y de la enfermedad del higado graso no alcohólico.
US20180050078A1 (en) * 2015-03-03 2018-02-22 KOHJIN Life Sciences Co., Ltd. Composition for improving or preventing nonalcoholic fatty liver

Also Published As

Publication number Publication date
CA2978251A1 (en) 2016-09-09
US20180050078A1 (en) 2018-02-22
RU2746091C2 (ru) 2021-04-06
AU2016226906B2 (en) 2021-06-10
EP3266461A1 (en) 2018-01-10
PH12017550090B1 (en) 2018-02-12
BR112017018882A2 (pt) 2018-04-17
CA2978251C (en) 2023-08-29
RU2017134036A (ru) 2019-04-05
PH12017550090A1 (en) 2018-02-12
US20200289605A1 (en) 2020-09-17
JP7130725B2 (ja) 2022-09-05
WO2016140237A1 (ja) 2016-09-09
US20190125822A1 (en) 2019-05-02
JP2021054852A (ja) 2021-04-08
TW201639588A (zh) 2016-11-16
EP3266461A4 (en) 2018-11-14
JPWO2016140237A1 (ja) 2017-12-14
RU2017134036A3 (es) 2019-09-05
JP6890536B2 (ja) 2021-06-18
TWI781906B (zh) 2022-11-01
AU2016226906A1 (en) 2017-10-05
US11771735B2 (en) 2023-10-03
US20220072083A1 (en) 2022-03-10
US11207371B2 (en) 2021-12-28
CN107405376A (zh) 2017-11-28

Similar Documents

Publication Publication Date Title
PH12017550090A1 (en) Composition for improving or preventing nonalcoholic fatty liver
MA42560A (fr) Compositions comprenant des souches bactériennes de blautia pour le traitement de l'hypersensibilité viscérale
MA41013A (fr) Compositions comprenant des souches bactériennes
MX2017008844A (es) Terapia de combinacion con inhibidor de acetil-coa carboxilasa (acc) para el tratamiento de enfermedad de higado graso no alcoholico.
EA201790170A1 (ru) Терапевтические соединения-ингибиторы
MX2019003623A (es) Composiciones y metodos para el tratamiento de afecciones oftalmicas.
GEP20247593B (en) Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders
WO2019118638A3 (en) Rnai constructs for inhibiting pnpla3 expression
PH12016501441A1 (en) Chimeric alkaline phosphate-like proteins
WO2016061509A8 (en) Compositions and methods of treating muscular dystrophy
WO2015185875A9 (fr) Anticorps dirigé contre la galectine 9 et inhibiteur de l'activité suppressive des lymphocytes t régulateurs
MX2020003581A (es) Compuestos monobactamicos cromanos para el tratamiento de infecciones bacterianas.
MX2020006237A (es) Compuestos para el tratamiento de enfermedades relacionadas con la expresion de dux4.
BR112018071467A2 (pt) método de tratamento ou prevenção de patologias hepáticas
WO2016094834A3 (en) A method for treating a complement mediated disorder caused by an infectious agent in a patient
BR112017015775A2 (pt) composições de limpeza e/ou tratamento
PH12017500615A1 (en) Ophthalmic composition comprising cyclosporine and trehalose
WO2016079110A3 (en) Use of enzyme for cleaning
MX2017006709A (es) Agente para prevenir o mejorar sintomas causados por desequilibrio de las hormonas sexuales.
BR112017016760A2 (pt) composições antimicrobianas
SG11201804160SA (en) Composition for inhibiting carnosine dipeptidase
BR112016023519A2 (pt) inibidor de sinalização de wnt/ß-catenina, composição farmacêutica e método de tratamento e/ou prevenção de uma patologia definida por malformação vascular
MX2016010699A (es) Composiciones y metodos para tratar neutropenia.
MX2018009662A (es) Metodo y composicion farmaceutica para tratamiento de neurodegeneracion.
EP3777848A4 (en) COMPOSITION FOR THE PREVENTION OR TREATMENT OF STROKE